Recital A Sample Clauses

Recital A. The second sentence of Recital A to the Agreement hereby is amended by deleting therefrom: "and all shares of Preferred Stock and Common Stock hereafter acquired by Executive".

Recital A. The phrase “Four Million Dollars ($4,000,000)” in Recital A of the Securities Purchase Agreement is hereby deleted and replaced with “Five Million Dollars ($5,000,000)”.

Recital A. Recital A of the Loan Agreement is amended in its entirety and replaced with the following: A. The Borrowers have requested that the Lender make available to the Borrowers Term Loan Advances in an aggregate principal amount of up to Twenty-Five Million Dollars ($25,000,000) (the “Term Loan”);” Section 1.1 (Definitions and Rules of Construction). The following definitions set forth in Section 1.1 of the Loan Agreement shall be amended in their entirety and replaced with the following:

Recital A. Recital A shall be amended by the insertion of --------- ",SolutionExplorer(TM) software, an Internet browser based application, that allows remote service professionals and other analysts to solve problems in broadly the same manner as the SolutionBuilder application" before ", and SolutionPublisher(R) software".

Recital A. Recital “A” of the Agreement shall be deleted in its entirety and replaced with the following: A. CBAI has issued to Secured Party a certain Secured Convertible Promissory Note dated June 27, 2012, in the face amount of $1,252,000 (as the same may be amended, and including any promissory note for which said note is subsequently exchanged, the “Note”).”

Recital A. Recital A of the Stockholders Agreement is hereby amended and restated to read in its entirety as follows: “The Company has entered into that certain Series F Preferred Stock Purchase Agreement, dated as of September 15, 2014 (as the same may be amended from time to time, the “Purchase Agreement”), pursuant to which the Company has agreed to issue and sell up to an aggregate of 17,266,187 shares of its Series F Convertible Preferred Stock, $.01 par value (collectively, the “Series F Preferred”) at $1.39 per share at one or more closings (the “Financing”).”

Recital A. Recital A of the Pledge Agreement is hereby amended to read in full as follows: Pursuant to that certain Second Amended and Restated Credit Agreement dated as of August 16, 2000 among Tracinda Corporation, a Nevada corporation (the “Company”), the several financial institutions from time to time parties thereto (each a “Lender” and collectively, the “Lenders”) and the Administrative Agent (as amended, restated or supplemented or otherwise modified from time to time, the “Credit Agreement”), the Lenders have agreed to extend credit facilities to the Company on the terms and conditions set forth therein. The Credit Agreement amends and restates in its entirety that certain First Amended and Restated Credit Agreement dated as of October 30, 1996, as amended, among the Company, the banks party thereto, and Bank of America, N.A. (formerly known as Bank of America National Trust and Savings Association), as Letter of Credit Issuing Bank and Administrative Agent for the banks party thereto. Unless otherwise defined herein, capitalized terms used herein are used with the same defined meanings given in the Credit Agreement.

Recital A. Recital A of the Shareholder Agreement is hereby amended and restated in its entirety as follows: A. The Corporation will issue 1,000,000 shares of Series A Preferred Stock to the Series A Preferred Stockholder pursuant to the Certificate of Determination of Preferences of Series A Preferred Stock of Allied Physicians of California, A Professional Medical Corporation, dated September 11, 2019, a copy of which is attached as Exhibit A hereto (the “Certificate of Determination”).

Recital A. DMR........................................................................ 1.2(b) FDA.................................................................. 2.1(d),.5.1 Firm Order Period............................................................. 1.3 Instrument............................................................. Recital A SeaMED..................................................................... Intro Specifications............................................................. 1.2(a) System................................................................. Recital A